Subsequent reduction of insurance prices deteriorating domestic pharmaceutical business

Published: 2002-07-15 06:59:00

Updated: 2002-07-15 06:59:00

Business observers say that the recent government drug-related polices designed to reduce the insurance-covered drugs have dragged the overall pharmaceutical business into a serious setback, following a series of insurance price reductions: (1) average 2.9 percent drop on 781 items (136 firms) on...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK